Evelyn Partners Asset Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.31M Buy
17,630
+483
+3% +$113K 1.06% 35
2025
Q4
$3.55M Sell
17,147
-226
-1% -$44.7K 0.83% 40
2025
Q3
$3.22M Buy
17,373
+964
+6% +$165K 0.73% 41
2025
Q2
$2.51M Buy
16,409
+670
+4% +$103K 0.64% 42
2025
Q1
$2.61M Buy
15,739
+771
+5% +$121K 0.73% 40
2024
Q4
$2.16M Buy
+14,968
New +$2.32M 0.58% 45

Other funds holding JNJ

Evelyn Partners Asset Management's JNJ Position: Q1 2026 in Review

Evelyn Partners Asset Management increased its Johnson & Johnson (JNJ) stake by 2.8% in Q1 2026, buying an estimated $113K and bringing the position to 17,630 shares worth $4.31M. The position accounts for 1.06% of the portfolio, ranked #35.

Evelyn Partners Asset Management first reported a position in JNJ in Q4 2024 and has held it in 6 quarters since. 4,648 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Evelyn Partners Asset Management held 17,630 shares of Johnson & Johnson worth $4.31M as of Q1 2026.
  • Evelyn Partners Asset Management bought 483 Johnson & Johnson shares in Q1 2026, an estimated $113K.
  • Johnson & Johnson made up 1.06% of Evelyn Partners Asset Management's portfolio in Q1 2026, its #35 holding.
  • Evelyn Partners Asset Management first reported a position in Johnson & Johnson in Q4 2024 and has held it in 6 quarters since.
  • 4,648 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Evelyn Partners Asset Management's 13F filing for Q1 2026, filed 15 May 2026.